This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gronchi, A. Articles by Rosai, J. Search for Related Content PubMed PubMed Citation Articles by Gronchi, A. Articles by Rosai, J. Social Bookmarking                            What's this?

Quality of Surgery and Outcome in Extra-Abdominal Aggressive Fibromatosis: A Series of Patients Surgically Treated at a Single Institution

From the Departments of Surgery, Medical Oncology, Biostatistics, Pathology, and Radiation Oncology, Istituto Nazionale per lo studio e la cura dei Tumori, Milan, Italy.

Address reprint requests to Alessandro Gronchi, MD, Department of Surgery, Istituto Nazionale per lo studio e la cura dei Tumori, via Venezian 1, 20133 Milano, Italy; email: alessandro.gronchi{at}istitutotumori.mi.it.

Purpose: To explore prognostic factors in surgically treated aggressive fibromatosis (extra-abdominal desmoid tumor).

Patients and Methods: A total of 203 consecutive patients treated with surgery over a 35-year period at a single referral center were retrospectively reviewed. One hundred twenty-eight were first seen at our institution with primary disease, whereas 75 had a recurrent tumor. All patients underwent macroscopically complete resection. Margins were rated as negative in 146 (97 with primary tumors, 49 with recurrences) and positive in 57 (31 in primary, 26 in recurrences) patients. Median follow-up was 135 months.

Results: Patients with primary disease had a better disease-free survival rate than those with recurrence (76% v 59% at 10 years). Presenting with a recurrence was also the strongest predictor of local failure in the multivariate analysis. In patients first treated for primary disease, size and site had prognostic significance, whereas microscopically positive surgical margins did not. In contrast, in patients with recurrence, there was a trend toward better prognosis if margins were negative (although this was not significant at multivariate analysis).

Conclusion: Presence of microscopic disease does not necessarily affect long-term disease-free survival in patients with primary presentation of extra-abdominal desmoid tumors. Thus, function-sparing surgery may be a reasonable choice when feasible without leaving macroscopic residual disease. In patients with recurrences, positive margins may more clearly affect prognosis, potentially necessitating adjuvant radiation in selected cases.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. D. Murphey, C. M. Ruble, S. M. Tyszko, A. M. Zbojniewicz, B. K. Potter, and M. Miettinen Continuing Medical Education@;DELIM@;From the Archives of the AFIP: Musculoskeletal Fibromatoses: Radiologic-Pathologic Correlation RadioGraphics, November 1, 2009; 29(7): 2143 - 2183. [Abstract] [Full Text] [PDF]

				A. J.F. Lazar, D. Tuvin, S. Hajibashi, S. Habeeb, S. Bolshakov, E. Mayordomo-Aranda, C. L. Warneke, D. Lopez-Terrada, R. E. Pollock, and D. Lev Specific Mutations in the {beta}-Catenin Gene (CTNNB1) Correlate with Local Recurrence in Sporadic Desmoid Tumors Am. J. Pathol., November 1, 2008; 173(5): 1518 - 1527. [Abstract] [Full Text] [PDF]

				H. S. Hosalkar, J. T. Torbert, E. J. Fox, T. F. Delaney, A. J. Aboulafia, and R. D. Lackman Musculoskeletal Desmoid Tumors J. Am. Acad. Ortho. Surg., April 1, 2008; 16(4): 188 - 198. [Abstract] [Full Text] [PDF]

				D. Lev, D. Kotilingam, C. Wei, M. T. Ballo, G. K. Zagars, P. W.T. Pisters, A. A. Lazar, S. R. Patel, R. S. Benjamin, and R. E. Pollock Optimizing Treatment of Desmoid Tumors J. Clin. Oncol., May 1, 2007; 25(13): 1785 - 1791. [Abstract] [Full Text] [PDF]

				S. X. Skapek, W. S. Ferguson, L. Granowetter, M. Devidas, A. R. Perez-Atayde, L. P. Dehner, F. A. Hoffer, R. Speights, M. C. Gebhardt, G. V. Dahl, et al. Vinblastine and Methotrexate for Desmoid Fibromatosis in Children: Results of a Pediatric Oncology Group Phase II Trial J. Clin. Oncol., February 10, 2007; 25(5): 501 - 506. [Abstract] [Full Text] [PDF]

				W. K. de Jong, W. T. A. van der Graaf, E. J. van der Jagt, T. J. Klinkenberg, H. J. M. Groen, W. Timens, and W. R. Douma A 20-year-old male with thoracic pain and a lower thoracic mass Eur. Respir. J., October 1, 2005; 26(4): 740 - 744. [Full Text] [PDF]

				A. E. Abbas, C. Deschamps, S. D. Cassivi, F. C. Nichols III, M. S. Allen, C. D. Schleck, and P. C. Pairolero Chest Wall Desmoid Tumors: Results of Surgical Intervention Ann. Thorac. Surg., October 1, 2004; 78(4): 1219 - 1223. [Abstract] [Full Text] [PDF]